A Trial Using Molecular-Guided Therapy in Patients With Refractory or Recurrent Neuroblastoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01109238
Recruitment Status : Completed
First Posted : April 23, 2010
Last Update Posted : July 22, 2013
Van Andel Research Institute
Information provided by (Responsible Party):
Giselle Sholler, Spectrum Health Hospitals

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : July 2010
  Study Completion Date : July 2010